Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 22 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-7.65 Insider Own46.42% Shs Outstand1.65M Perf Week-1.67%
Market Cap7.30M Forward P/E- EPS next Y-3.17 Insider Trans0.00% Shs Float0.89M Perf Month-2.45%
Income-23.87M PEG- EPS next Q-1.41 Inst Own45.34% Short Float0.36% Perf Quarter-32.44%
Sales0.00M P/S- EPS this Y77.02% Inst Trans-49.21% Short Ratio0.91 Perf Half Y16.14%
Book/sh-1.27 P/B- EPS next Y18.54% ROA-115.45% Short Interest0.00M Perf Year-67.08%
Cash/sh3.40 P/C1.30 EPS next 5Y- ROE-1278.60% 52W Range3.57 - 13.50 Perf YTD16.45%
Dividend Est.- P/FCF- EPS past 5Y- ROI-464.30% 52W High-67.22% Beta1.34
Dividend TTM- Quick Ratio0.83 Sales past 5Y0.00% Gross Margin- 52W Low24.11% ATR (14)0.28
Dividend Ex-Date- Current Ratio0.83 EPS Y/Y TTM-275.21% Oper. Margin0.00% RSI (14)42.27 Volatility2.78% 5.82%
Employees62 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.67 Target Price12.33
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-1056.38% Payout- Rel Volume0.99 Prev Close4.40
Sales Surprise- EPS Surprise-10.79% Sales Q/Q- EarningsFeb 14 BMO Avg Volume3.58K Price4.43
SMA20-4.22% SMA50-17.22% SMA200-33.32% Trades Volume3,559 Change0.57%
Date Action Analyst Rating Change Price Target Change
Sep-14-21Initiated JMP Securities Mkt Outperform $14
Jul-30-21Initiated Cantor Fitzgerald Overweight $24
Nov-24-20Upgrade Raymond James Outperform → Strong Buy
Aug-10-20Initiated Alliance Global Partners Buy $27
Jul-21-20Initiated Raymond James Outperform $23
Jul-21-20Initiated BMO Capital Markets Outperform $30
Jul-21-20Initiated Barclays Overweight $22
Feb-28-24 07:00AM
Feb-19-24 12:00PM
Feb-15-24 09:41AM
Feb-14-24 07:00AM
Feb-12-24 07:00AM
07:00AM Loading…
Jan-31-24 07:00AM
Jan-04-24 04:32PM
Nov-12-23 10:40AM
Nov-08-23 07:00AM
Nov-07-23 07:00AM
Nov-01-23 07:00AM
Oct-11-23 07:00AM
Oct-09-23 07:00AM
Oct-04-23 07:00AM
Sep-22-23 07:00AM
07:34AM Loading…
Sep-21-23 07:34AM
Sep-20-23 09:15AM
Sep-19-23 07:00AM
Aug-09-23 07:00AM
Jul-26-23 07:00AM
Jun-29-23 08:00AM
Jun-22-23 07:00AM
Jun-05-23 04:02PM
May-22-23 09:00AM
May-13-23 12:30PM
May-10-23 07:00AM
May-09-23 07:15AM
Apr-26-23 07:00AM
Apr-24-23 07:00AM
Apr-14-23 04:01PM
12:00PM Loading…
Mar-31-23 12:00PM
Mar-29-23 07:59AM
Mar-28-23 04:05PM
Mar-07-23 08:00AM
Feb-09-23 03:22PM
Feb-08-23 07:00AM
Jan-31-23 07:00AM
Jan-24-23 07:00AM
Jan-03-23 07:00AM
Dec-12-22 07:00AM
Dec-09-22 04:01PM
Nov-29-22 07:00AM
Nov-09-22 07:00AM
Oct-26-22 07:00AM
Oct-20-22 07:09AM
Sep-28-22 08:57AM
Sep-19-22 07:00AM
Sep-12-22 07:00AM
Sep-06-22 03:25PM
Sep-02-22 10:04AM
Aug-31-22 09:55AM
Aug-30-22 07:00AM
Aug-15-22 12:00PM
Aug-10-22 07:00AM
Aug-03-22 07:00AM
Jul-27-22 07:00AM
Jul-25-22 07:00AM
Jul-05-22 07:00AM
Jun-15-22 07:00AM
Jun-06-22 07:00AM
Jun-02-22 07:00AM
Jun-01-22 07:00AM
May-31-22 07:00AM
May-23-22 12:04PM
May-16-22 09:55AM
May-11-22 07:00AM
Apr-27-22 07:00AM
Apr-25-22 07:30AM
Apr-12-22 08:00AM
Apr-06-22 07:00AM
Mar-28-22 02:11PM
Mar-08-22 07:00AM
Mar-02-22 07:00AM
Mar-01-22 07:00AM
Feb-09-22 07:00AM
Jan-26-22 07:30AM
Jan-04-22 07:30AM
Jan-03-22 07:30AM
Dec-27-21 09:22AM
Dec-14-21 03:26PM
Nov-18-21 07:00AM
Nov-16-21 10:20AM
Nov-10-21 07:00AM
Nov-01-21 07:00AM
Sep-27-21 02:08PM
Sep-20-21 07:00AM
Sep-13-21 11:00AM
Aug-17-21 08:00AM
Aug-11-21 07:00AM
Aug-09-21 08:00AM
Jul-28-21 07:00AM
Jul-12-21 08:00AM
Jun-28-21 09:30AM
Jun-23-21 06:30AM
PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months. The firm's product candidates are designed to address unmet medical needs by delivering active pharmaceutical ingredients, or APIs, locally at predetermined release rates and durations over extended periods ranging from days to several months. The company was founded by Noam Emanuel on February 28, 2008 and is headquartered in Petach Tikva, Israel.